Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04943211 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging

Study acronym: HISTIOGEN
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Eligibility criteria expanded, about 6 words
    • Site details revised
    • Publications: details revised at 10 of 11 entries
  2. Re-verified, no change to tracked fieldsv8
  3. Primary and study completion dates: Mar 30, 2026 to Jun 30, 2027v7
  4. Re-verified, no change to tracked fieldsv6
  5. Study completion date: Jun 23, 2026 to Mar 30, 2026v5
Show 3 earlier versionsHide 3 earlier versions
  1. Study title shortened, about 9 wordsv4
  2. Re-verified, no change to tracked fieldsv3
  3. Eligibility criteria revised
    • Study description shortened, about 2 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective, low intervention, open, single-center, non-commercial clinical trial to improve diagnostics in patients with histiocytosis by assessing the molecular profile of the tumor tissues, monitoring its presence in free-circulating DNA, and determining the efficacy of fluorodeoxyglucose (18F-FDG) in PET-CT imaging.
Trial Details
NCT Number NCT04943211
Lead Sponsor Anna Raciborska
Collaborators: Maria Sklodowska-Curie National Research Institute of Oncology, Łukasiewicz Research Network, Wroclaw University of Environmental and Life Sciences
Conditions
(from sponsor)		 Histiocytosis
Related terms Histiocytosis, Histiocytosis, Langerhans-Cell
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov